The Biology: Microvascular Disease and Vasospasm
At a Glance
Nonobstructive coronary artery disease can cause heart symptoms even without a major blockage: the small vessels may not open enough, the artery lining may malfunction, or an artery may suddenly tighten. More than one problem can occur at once.
To understand conditions like INOCA or MINOCA, it helps to move past the traditional “plumbing” analogy of a clogged pipe. Instead, think of your heart’s blood supply as a sophisticated irrigation system. Even if the main supply pipes (the large arteries) are clear, the system can fail if the small sprinklers (the microvasculature) are broken or if the pipes themselves are prone to sudden, violent “cramps” (vasospasms).
These issues are not about blockages; they are about coronary vasomotor dysfunction—a failure of the blood vessels to control flow and pressure correctly [1][2]. This dysfunction can happen in the large arteries on the surface of the heart or in the vast network of tiny vessels buried deep within the heart muscle.
The Inner Lining: Endothelial Dysfunction
The “brain” of your blood vessels is a thin, delicate layer of cells called the endothelium. It lines every artery in your body and acts like a chemical command center. When your heart needs more blood—such as during exercise—the endothelium releases signals (like nitric oxide) that tell the vessels to relax and widen [3].
In endothelial dysfunction, this signaling system breaks down. Instead of widening, the vessels may stay the same size or even narrow when they should be opening [4][5]. This is an important functional contributor that can lead to the other conditions described below. It is frequently influenced by inflammation, oxidative stress, and cardiovascular risk factors [3][6].
The Micro-Plumbing: Coronary Microvascular Dysfunction (CMD)
While an angiogram only shows the large arteries, a vast network of your heart’s blood vessel supply is made of tiny vessels called the microvasculature [7]. Coronary Microvascular Dysfunction (CMD) occurs when these tiny vessels cannot dilate enough to meet the heart’s demand for oxygen.
CMD can be caused by two main problems:
- Structural Issues: The tiny vessels may become scarred, thickened, or physically reduced in number (capillary rarefaction), making it harder for blood to squeeze through [7][8].
- Functional Issues: The vessels may be physically intact but fail to respond to the body’s signals to dilate, often related to the endothelial dysfunction mentioned above [9].
The “Cramp”: Vasospasm
Sometimes the heart muscle doesn’t get enough blood because the arteries suddenly and forcefully constrict, or “spasm.” This can happen in two different areas of the heart:
- Epicardial Vasospasm: A spasm in the large surface arteries. This can temporarily shut off blood flow completely, often causing intense chest pain at rest or in the middle of the night [4][10].
- Microvascular Spasm: A spasm in the tiny vessels. Because these vessels are so small, the spasm doesn’t show up as a visible “pinch” on an angiogram, but it still starves the heart muscle of oxygen and causes significant pain [5][4].
The Role of Estrogen and Menopause
Women are significantly more likely to experience these “functional” heart issues than men, and biology plays a central role in this difference. Estrogen is known to have protective effects, helping the endothelium stay healthy and keeping blood vessels flexible and responsive [11][12].
As estrogen levels decline during the transition to menopause, the blood vessels can lose this natural protection. This “estrogen withdrawal” is a biologically plausible contributor that can be associated with:
- Increased Inflammation: Higher levels of inflammatory markers that irritate the vessel lining [6].
- Reduced Nitric Oxide: A decrease in the chemical that tells vessels to relax [3].
- Vessel Stiffness: The arteries may become less flexible and more prone to spasms [12].
This hormonal shift is one reason why many women find that their heart symptoms begin or significantly worsen during perimenopause or in the years following menopause [13][12]. It is vital to state that menopausal hormone therapy is not a general treatment for NOCAD or cardiovascular prevention, and any use of it should only follow an individualized clinician risk assessment.
Understanding Your “Endotype”
It is common to have more than one of these issues at the same time. For example, you might have CMD (poor flow in the tiny vessels) along with epicardial spasms (sudden cramping in the large vessels) [14][15]. Doctors call these different categories endotypes. Identifying your specific endotype is crucial because a medication that helps with spasms might not be the best choice for structural microvascular disease [16][17]. Your symptoms are not just “one thing”; they are the result of how your unique blood vessels are functioning—or struggling—every day.
Common questions in this guide
Can nonobstructive coronary artery disease cause chest pain without a major blockage?
What is coronary microvascular dysfunction?
Can a coronary artery spasm cause pain at rest or at night?
Why might symptoms change around perimenopause or menopause?
What does an endotype mean in nonobstructive coronary artery disease?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did my diagnostic testing evaluate the function of my endothelium (the artery lining) specifically?
- 2.Based on my results, do I have a 'vasodilator' issue (difficulty opening) or a 'vasoconstrictor' issue (excessive tightening), or both?
- 3.Does my diagnosis involve the 'big pipes' (epicardial arteries) or the 'micro-plumbing' (microvasculature)?
- 4.Given my hormonal status (perimenopause/menopause), how might estrogen levels be influencing my heart symptoms?
- 5.If my symptoms are worse at rest or at night, could that indicate epicardial or microvascular spasm?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Endothelium in Coronary Macrovascular and Microvascular Diseases.
Godo S, Takahashi J, Yasuda S, Shimokawa H
Journal of cardiovascular pharmacology 2021; (78(Suppl 6)):S19-S29 doi:10.1097/FJC.0000000000001089.
PMID: 34840261 - 2
Pathophysiology and Diagnosis of Coronary Functional Abnormalities.
Takahashi J, Suda A, Nishimiya K, et al.
European cardiology 2021; (16()):e30 doi:10.15420/ecr.2021.23.
PMID: 34603510 - 3
Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction.
Godo S, Takahashi J, Yasuda S, Shimokawa H
European cardiology 2021; (16()):e13 doi:10.15420/ecr.2020.47.
PMID: 33897839 - 4
Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease.
Tjoe B, Pacheco C, Suppogu N, et al.
American heart journal plus : cardiology research and practice 2025; (53()):100527 doi:10.1016/j.ahjo.2025.100527.
PMID: 40182421 - 5
Feasibility and Impact of Invasive Coronary Function Testing in Ischemia and No Obstructive Coronary Arteries: A Single-Center Study.
Acharya D, Alvarez YR, Samuels B, et al.
Journal of the Society for Cardiovascular Angiography & Interventions 2026; (5(4)):104272 doi:10.1016/j.jscai.2026.104272.
PMID: 42111098 - 6
Do menopausal symptoms signal early biological aging? Mitochondrial, endocrine and clinical insights.
Blümel JE, Chedraui P, Vallejo MS
Climacteric : the journal of the International Menopause Society 2026; (29(3)):358-363 doi:10.1080/13697137.2026.2663898.
PMID: 42065350 - 7
Exploring coronary microvascular dysfunction from functional impairment and structural damage.
Wen W, Zhang Y, Jia G, Chi Y
Frontiers in cardiovascular medicine 2025; (12()):1600947 doi:10.3389/fcvm.2025.1600947.
PMID: 41696543 - 8
Coronary Microvascular Dysfunction and Hypertension: A Bond More Important than We Think.
Zdravkovic M, Popadic V, Klasnja S, et al.
Medicina (Kaunas, Lithuania) 2023; (59(12)) doi:10.3390/medicina59122149.
PMID: 38138252 - 9
Physiological Stratification of Patients With Angina Due to Coronary Microvascular Dysfunction.
Rahman H, Demir OM, Khan F, et al.
Journal of the American College of Cardiology 2020; (75(20)):2538-2549 doi:10.1016/j.jacc.2020.03.051.
PMID: 32439003 - 10
The Need for Separate Testing with Acetylcholine for the Assessment of Endothelial Dysfunction and Coronary Artery Spasm.
Sueda S, Sakaue T
European cardiology 2024; (19()):e17 doi:10.15420/ecr.2022.16.
PMID: 39449721 - 11
Metabolic Profile of Patients with Premature Ovarian Insufficiency.
Podfigurna A, Stellmach A, Szeliga A, et al.
Journal of clinical medicine 2018; (7(10)) doi:10.3390/jcm7100374.
PMID: 30347864 - 12
Interplay of menopause, coronary artery calcium score and cardiovascular disease risk.
Mishra T, Pasnoor DS, Gandhi M, et al.
World journal of cardiology 2025; (17(11)):109627 doi:10.4330/wjc.v17.i11.109627.
PMID: 41356582 - 13
Cardiovascular health and ovarian aging.
Quinn MM, Cedars MI
Fertility and sterility 2018; (110(5)):790-793 doi:10.1016/j.fertnstert.2018.07.1152.
PMID: 30316413 - 14
Comprehensive Endotyping of Patients With Angina and Nonobstructive Coronary Arteries: A Report From the J-CMD.
Hada M, Kakuta T, Ueno H, et al.
Journal of the American Heart Association 2026; (15(12)):e048016 doi:10.1161/JAHA.125.048016.
PMID: 42261982 - 15
Diagnostic Yield of Comprehensive Coronary Function Testing in Patients with Angina and Unobstructed Coronary Arteries: Endotype Characterisation and Clinical Implications.
McChord J, Hubert A, Sechtem U, et al.
European cardiology 2024; (19()):e19 doi:10.15420/ecr.2024.32.
PMID: 39588253 - 16
Diagnostic approach in patients with angina and no obstructive coronary artery disease: emphasising the role of the coronary function test.
Konst RE, Damman P, Pellegrini D, et al.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2021; (29(3)):121-128 doi:10.1007/s12471-020-01532-9.
PMID: 33415605 - 17
Functional coronary vascular disease: endotype-based classification, diagnosis, and targeted management.
El Khatib O, Al Azzoni A, Shantouf R, Atallah B
Frontiers in cardiovascular medicine 2026; (13()):1811419 doi:10.3389/fcvm.2026.1811419.
PMID: 42548607
This page explains how small-vessel dysfunction, endothelial problems, and vasospasm can contribute to nonobstructive coronary artery disease for informational purposes only and does not constitute medical advice. Your cardiologist should interpret your symptoms and test results and discuss whether menopause or other factors are relevant.
Get notified when new evidence is published on nonobstructive coronary artery disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.